Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products
- Conditions
- Vaginal Prolapse
- Interventions
- Device: AMS Prolapse Product
- Registration Number
- NCT00388947
- Lead Sponsor
- ASTORA Women's Health
- Brief Summary
This registry was observational (only collected information typically noted by the surgeon when their patients were routinely seen); there was no change to the care the patient received as a result of being part of the registry). Data collection focused on the surgical outcomes of AMS prolapse products.
- Detailed Description
The Prolapse Registry was an observational study of patients who were implanted with AMS devices for the surgical repair of female pelvic prolapse. The registry followed patients post-operatively for up to 2 years and collected demographic, clinical, surgical, safety, and patient outcomes data.
The registry was a web-based system in which surgeons entered patient information with regard to their prolapse surgery. All information entered was de-identified (no names, no date of birth, no date of surgery, etc).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1543
- Female at least 21 years old
- Has pelvic organ prolapse requiring surgical repair
- Receives at least one of the AMS Prolapse Repair devices in the treatment of their pelvic organ prolapse
- Is contraindicated for an AMS Prolapse Repair per the product's Instruction for Use.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 AMS Prolapse Product AMS Prolapse Product (AMS Apogee™ with IntePro (Synthetic) or InteXen (Biologic) Mesh implant for posterior wall pelvic organ prolapse AMS Straight-In™ with IntePro (Synthetic) Mesh implant for vaginal vault pelvic organ prolapse AMS Perigee™ with IntePro Mesh implant for anterior wall pelvic organ prolapse AMS Perigee™ with IntePro Mesh coated with PC AMS Elevate® Prolapse Repair System Family)
- Primary Outcome Measures
Name Time Method Count of Patients With at Least One Adverse Event Related to Any AMS Prolapse Device up to 2-years post-implant
- Secondary Outcome Measures
Name Time Method Prolapse Efficacy Success Rate 24 months Success was defined as either (1) Baden-Walker grade 0 or 1 or (2) (Pelvic Organ Prolapse Quantification System) POP-Q stage 0 or 1. If a site reported both measurements, then the POP-Q score was used.
Trial Locations
- Locations (1)
Samuel Zylstra, MD
🇺🇸Whitinsville, Massachusetts, United States